Adeshwar Meditex Ltd
Incorporated in 2007, Adeshwar Meditex Ltd is a manufacturer and exporter of sterile surgical wound dressings and medical disposables[1]
- Market Cap ₹ 25.3 Cr.
- Current Price ₹ 17.5
- High / Low ₹ 21.8 / 13.0
- Stock P/E 20.0
- Book Value ₹ 26.5
- Dividend Yield 0.00 %
- ROCE 5.21 %
- ROE 3.35 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.66 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -3.19% over past five years.
- Company has a low return on equity of 4.89% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 58.60 | 52.92 | 56.12 | 65.97 | 64.76 | 82.36 | 79.85 | 83.71 | 56.10 | |
| 52.96 | 47.44 | 50.64 | 61.22 | 61.39 | 77.14 | 74.66 | 79.29 | 53.33 | |
| Operating Profit | 5.64 | 5.48 | 5.48 | 4.75 | 3.37 | 5.22 | 5.19 | 4.42 | 2.77 |
| OPM % | 9.62% | 10.36% | 9.76% | 7.20% | 5.20% | 6.34% | 6.50% | 5.28% | 4.94% |
| 0.10 | 0.25 | 0.28 | 0.13 | 0.23 | 0.31 | 0.13 | 0.26 | 0.10 | |
| Interest | 1.78 | 2.23 | 2.52 | 2.19 | 2.03 | 2.09 | 1.93 | 1.39 | 0.61 |
| Depreciation | 0.36 | 0.35 | 0.34 | 0.35 | 0.38 | 0.53 | 0.60 | 0.50 | 0.43 |
| Profit before tax | 3.60 | 3.15 | 2.90 | 2.34 | 1.19 | 2.91 | 2.79 | 2.79 | 1.83 |
| Tax % | 29.72% | 28.25% | 27.24% | 28.63% | 33.61% | 28.52% | 27.96% | 26.16% | 31.15% |
| 2.54 | 2.26 | 2.12 | 1.68 | 0.79 | 2.07 | 2.01 | 2.07 | 1.26 | |
| EPS in Rs | 5.10 | 4.54 | 4.03 | 1.60 | 0.55 | 1.43 | 1.39 | 1.43 | 0.87 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | -12% |
| TTM: | -33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -7% |
| 3 Years: | -15% |
| TTM: | -36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -8% |
| 3 Years: | -12% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.98 | 4.98 | 5.27 | 10.53 | 14.43 | 14.43 | 14.43 | 14.43 | 14.43 |
| Reserves | 8.55 | 10.81 | 13.64 | 10.05 | 16.52 | 18.48 | 20.48 | 22.53 | 23.85 |
| 11.58 | 19.92 | 21.32 | 22.45 | 18.99 | 16.43 | 13.89 | 12.45 | 6.00 | |
| 7.33 | 5.79 | 14.57 | 19.27 | 22.63 | 17.67 | 15.23 | 22.79 | 5.94 | |
| Total Liabilities | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 72.20 | 50.22 |
| 2.36 | 2.44 | 2.28 | 2.24 | 3.03 | 3.70 | 3.53 | 2.95 | 2.61 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.02 | 0.04 | 0.08 | 0.08 | 0.10 | 0.10 | 0.10 | 0.00 | 0.00 |
| 30.06 | 39.02 | 52.44 | 59.98 | 69.44 | 63.21 | 60.40 | 69.25 | 47.61 | |
| Total Assets | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 72.20 | 50.22 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| -0.99 | 3.15 | -2.44 | 5.77 | 3.84 | 3.80 | 4.97 | |||
| 1.58 | -0.71 | -1.16 | -1.16 | -0.22 | 0.51 | 0.10 | |||
| -0.07 | -3.11 | 4.44 | -4.63 | -4.36 | -2.66 | -7.09 | |||
| Net Cash Flow | 0.53 | -0.66 | 0.85 | -0.02 | -0.75 | 1.65 | -2.02 | ||
| Free Cash Flow | -1.17 | 2.83 | -3.61 | 4.57 | 3.41 | 3.86 | 4.89 | ||
| CFO/OP | -3% | 81% | -56% | 129% | 90% | 105% | 198% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 108.69 | 134.63 | 181.26 | 150.82 | 183.06 | 123.78 | 115.51 | 152.52 | 135.46 |
| Inventory Days | 64.44 | 112.51 | 119.36 | 174.35 | 168.24 | 127.72 | 138.71 | 126.64 | 159.17 |
| Days Payable | 43.11 | 38.76 | 104.70 | 119.86 | 138.51 | 88.18 | 75.97 | 104.03 | 37.50 |
| Cash Conversion Cycle | 130.02 | 208.39 | 195.93 | 205.31 | 212.79 | 163.33 | 178.25 | 175.13 | 257.13 |
| Working Capital Days | 129.43 | 108.29 | 124.03 | 111.49 | 147.05 | 116.60 | 129.04 | 135.78 | 225.25 |
| ROCE % | 17.69% | 14.27% | 11.22% | 6.93% | 10.07% | 9.62% | 8.27% | 5.21% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Number of Permanent Employees Count |
|
|||||
| Foreign Exchange Earnings (Export Revenue) Rs. in lacs |
||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Meeting Of Board Of Adeshwar Meditex Limited To Be Held On August 26, 2026 At 04:00 PM (IST) At The Registered Office Of The Company.
- Board meets on 26 Aug 2026 to consider independent director appointment, AGM notice, book closure, and director’s report.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
- Mr. Satish Chudekar resigned as Non-Executive Non-Independent Director on 3 August 2026 due to personal commitments.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Adeshwar Meditex Limited has submitted to the exchange the Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
-
Clarification Letter On Outcome Of Board Meeting Submitted On May 21, 2026
- Adeshwar Meditex corrected board outcome typos in related party transaction amounts on May 22, 2026.
-
Board Meeting Outcome for Oucome Of Board Meeting For FY 2026-27 Held Today I.E May 21, 2026 Through Video Conferencing
- Board approved FY26 audited results, director resignation/appointment, and discussed up to Rs 40 crore equity raise.
Business Overview:[1]
AML is engaged in end‑to‑end manufacturing, trading, and distribution of surgical, pharmaceutical, hygiene, protective, and laboratory products, with capabilities
extending to turnkey projects and allied services